Analysts have provided the following ratings for Ascendis Pharma ASND within the last quarter:

According to 13 analyst offering 12-month price targets in the last 3 months, Ascendis Pharma has an average price target of $130.46 with a high of $187.00 and a low of $89.00.

Below is a summary of how these 13 analysts rated Ascendis Pharma over the past 3 months. The greater the number of bullish ratings, the more positive analysts are on the stock and the greater the number of bearish ratings, the more negative analysts are on the stock

This average price target has increased by 0.45% over the past month.

Stay up to date on Ascendis Pharma analyst ratings.

What Are Analyst Ratings?

Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.

Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.

This article was generated by Benzinga's automated content engine and reviewed by an editor.